title: Direct cytotoxicity of ethylcholine mustard aziridinium in cerebral microvascular endothelial cells.
abstract: The choline analogue ethylcholine mustard aziridinium (AF64A) is a potent and irreversible inhibitor of choline uptake in brain synaptosomes and is used as a neurotoxin to produce animal models of cholinergic hypofunction. However, previous studies have shown that intraocular administration of AF64A in rats not only reduced the number of cholinergic neurons in the retina, but also induced ultrastructural alterations in the microvasculature. The purpose of this study was to investigate whether AF64A has a direct cytotoxic effect on endothelial cells. As revealed by the measurement of lactate dehydrogenase activity in the culture medium, AF64A produced similar concentration-dependent cellular damage in cultures of bovine cerebral endothelial cells and in the human cholinergic neuroblastoma cell line SK-N-MC, but not in bovine cerebral smooth muscle cells. The toxic effect of AF64A correlated well with the affinity of the choline transport system detected in each cell type. The effect of the toxin on endothelial cells was mediated by its interaction with the endothelial cell choline carrier, as demonstrated by the following observations: (a) AF64A inhibited [3H]choline uptake in a concentration-dependent manner in both cultured and freshly isolated cerebral endothelial cells, and (b) the addition of choline or hemicholinium-3 to the culture medium prevented the AF64A-induced toxicity in endothelial cell cultures.
authors.affiliation: Department of Physiology, School of Medicine, Universidad Autónoma de Madrid, Spain.
authors.forename: C
authors.initials: C
authors.lastname: Gómez
authors.forename: C
authors.initials: C
authors.lastname: Martín
authors.forename: E
authors.initials: E
authors.lastname: Galea
authors.forename: C
authors.initials: C
authors.lastname: Estrada
mesh_terms: D000818:Animals; D001388:Aziridines / Q000494:pharmacology / Q000633:toxicity*; D001692:Biological Transport / Q000187:drug effects; D001921:Brain / Q000098:blood supply*; D002417:Cattle; D016923:Cell Death / Q000187:drug effects; D002478:Cells, Cultured; D002794:Choline / Q000031:analogs & derivatives* / Q000378:metabolism / Q000494:pharmacology / Q000633:toxicity; D002795:Choline O-Acetyltransferase / Q000378:metabolism; D004730:Endothelium, Vascular / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D006426:Hemicholinium 3 / Q000494:pharmacology; D006801:Humans; D007770:L-Lactate Dehydrogenase / Q000378:metabolism; D008833:Microcirculation / Q000166:cytology / Q000187:drug effects; D009447:Neuroblastoma / Q000473:pathology; D014118:Toxins, Biological / Q000494:pharmacology; D014407:Tumor Cells, Cultured
chemical_list: D001388:Aziridines; D014118:Toxins, Biological; D006426:Hemicholinium 3; C044894:ethylcholine aziridinium; D007770:L-Lactate Dehydrogenase; D002795:Choline O-Acetyltransferase; D002794:Choline